81322845-MAV+: Technical assistance for selected companies in the pharmaceutical sector in South Africa for the SAVax project (Германия - Тендер #71737426) | ||
| ||
| Для перевода текста тендера на нужный язык воспользуйтесь приложением: | ||
Страна: Германия (другие тендеры и закупки Германия) Организатор тендера: Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH Номер конкурса: 71737426 Дата публикации: 08-04-2026 Источник тендера: Единая система закупок Европейского союза TED |
||
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH (ID: ORG-0001)
Address: Dag-Hammarskjöld-Weg 1 - 5, Eschborn, 65760
Contacts:
Tel: +49 6196792510
Email: katharina.cheimanoff@giz.de
Web: https://www.giz.de
Company ID: 993-80072-52
Vergabekammern des Bundes (ID: ORG-0002)
Address: Kaiser-Friedrich-Straße 16, Bonn, 53113
Contacts:
Tel: +49 2289499-0
Email: vk@bundeskartellamt.bund.de
Web: https://www.bundeskartellamt.de
Company ID: 022894990
Datenservice Öffentlicher Einkauf (in Verantwortung des Beschaffungsamts des BMI) (ID: ORG-0003)
Address: , Bonn, 53119
Contacts:
Tel: +49228996100
Email: noreply.esender_hub@bescha.bund.de
Company ID: 0204:994-DOEVD-83
Description: The project "Vaccines for Africa: Roll out and Production in South Africa" (SAVax) is part of South Africa"s strategic objective to enhance the local production of vaccines, medicines, and health technologies. Co-financed by the German Federal Ministry for Economic Cooperation and Development (BMZ) and the European Union (EU), SAVax aims to strengthen local manufacturing capacity in the biopharmaceutical industry and improve access to essential health products. The initiative aligns with the goals of key South African government partners, including the Department of Science, Technology and Innovation (DSTI), the Department of Health (DoH), and the South African Health Products Regulatory Authority (SAHPRA), to create a sustainable and competitive biopharmaceutical sector. The project aims at supporting selected South African biopharmaceutical companies with "ready-for-market" products, providing targeted technical assistance to improve their manufacturing capacity, and enhancing market access at national, regional, and continental levels. These companies face challenges such as market intelligence gaps, demand forecasting difficulties, high production costs, and technology transfer obstacles, which impede their ability to meet growing health needs. Addressing these challenges requires long-term strategies, including off-take agreements, purchase guarantees, and investment in technology and skills development.
Issue Date: 01.04.2026 22:00
Submission Deadline: 08.04.2026 10:00
CPV Codes: 79411100, 73200000
Documentation: